Two-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected or vaccinated may be likely.
Researchers from the University of Oxford published results on Monday from a study yet to be peer-reviewed, where they analysed blood samples from participants who were given doses from AstraZeneca-Oxford or Pfizer-BioNTech in a large study looking into mixing of vaccines.
The results come a day after British Prime Minister Boris Johnson warned that two shots will not be enough to contain Omicron, following findings from the UK health agency last week that boosters significantly restore protection against the variant.
The Oxford study said that there was no evidence yet that the lower level of infection-fighting antibodies against Omicron could lead to higher risk of severe disease, hospitalisation or death in those who have got two doses of approved vaccines.
"These data are important but are only one part of the picture. They only look at neutralising antibodies after the second dose, but do not tell us about cellular immunity, and this will also be tested," said Matthew Snape, Oxford professor and co-author of the paper.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
From FLiRT To FLuQE: What To Know About The Latest Covid Variants Covid Still Kills 1,700 A Week Around World: WHO Bharat Biotech Adds Top Medical Body ICMR As Co-Owner Of Covid Vaccine Patent Rahul Gandhi's Seat At Red Fort Triggers Fresh Congress Attack On BJP 2 French Rafale Jets Collide Mid-Air, Instructor, Pilot Missing "Pivotal Moment": Key Doctor Body Resumes Strike 2 Days After Calling It Off Woman Shares Series Of Harassment Incidents On Delhi-NCR Streets 1 Arrested In Connection To "Friends" Actor Matthew Perry's Death: Report US State Arizona's Ballot Can Describe Fetuses As "Unborn" Humans: Court Track Latest News Live on NDTV.com and get news updates from India and around the world.